These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 24884470)

  • 21. Interfering with influenza: nonlinear coupling of reactive and static mitigation strategies.
    Zachreson C; Fair KM; Harding N; Prokopenko M
    J R Soc Interface; 2020 Apr; 17(165):20190728. PubMed ID: 32316882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiological and economic impact of pandemic influenza in Chicago: Priorities for vaccine interventions.
    Dorratoltaj N; Marathe A; Lewis BL; Swarup S; Eubank SG; Abbas KM
    PLoS Comput Biol; 2017 Jun; 13(6):e1005521. PubMed ID: 28570660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) during an annual influenza epidemic and influenza pandemic in China.
    Caldwell R; Roberts CS; An Z; Chen CI; Wang B
    BMC Infect Dis; 2015 Jul; 15():284. PubMed ID: 26206275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effective strategies for mitigating a future influenza pandemic with H1N1 2009 characteristics.
    Halder N; Kelso JK; Milne GJ
    PLoS One; 2011; 6(7):e22087. PubMed ID: 21760957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic value of seasonal and pandemic influenza vaccination during pregnancy.
    Beigi RH; Wiringa AE; Bailey RR; Assi TM; Lee BY
    Clin Infect Dis; 2009 Dec; 49(12):1784-92. PubMed ID: 19911967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
    Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K
    JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis.
    Brydak L; Roiz J; Faivre P; Reygrobellet C
    Clin Drug Investig; 2012 Feb; 32(2):73-85. PubMed ID: 22201294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cost comparison of electronic and hybrid data collection systems in Ontario during pandemic and seasonal influenza vaccination campaigns.
    Pereira JA; Foisy J; Kwong JC; Heidebrecht CL; Quach S; Quan SD; Guay M; Sander B;
    BMC Health Serv Res; 2011 Sep; 11():210. PubMed ID: 21880158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are we prepared for the next influenza pandemic? Lessons from modelling different preparedness policies against four pandemic scenarios.
    Panovska-Griffiths J; Grieco L; van Leeuwen E; Baguelin M; Pebody R; Utley M
    J Theor Biol; 2019 Nov; 481():223-232. PubMed ID: 31059716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US.
    Peasah SK; Meltzer MI; Vu M; Moulia DL; Bridges CB
    PLoS One; 2019; 14(4):e0213499. PubMed ID: 31034485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.
    de Boer PT; Nagy L; Dolk FCK; Wilschut JC; Pitman R; Postma MJ
    Value Health; 2021 Jan; 24(1):19-31. PubMed ID: 33431149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of inactivated influenza vaccination in children with medical risk conditions in the Netherlands.
    Naber SK; Bruijning-Verhagen PCJL; de Hoog MLA; van Giessen A
    Vaccine; 2020 Apr; 38(17):3387-3396. PubMed ID: 32115297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States.
    Clements KM; Meier G; McGarry LJ; Pruttivarasin N; Misurski DA
    Hum Vaccin Immunother; 2014; 10(5):1171-80. PubMed ID: 24609063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients.
    Wongsurakiat P; Lertakyamanee J; Maranetra KN; Jongriratanakul S; Sangkaew S
    J Med Assoc Thai; 2003 Jun; 86(6):497-508. PubMed ID: 12924797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal strategies of social distancing and vaccination against seasonal influenza.
    Shim E
    Math Biosci Eng; 2013; 10(5-6):1615-34. PubMed ID: 24245639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies.
    Jit M; Newall AT; Beutels P
    Hum Vaccin Immunother; 2013 Apr; 9(4):834-40. PubMed ID: 23357859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults.
    Raviotta JM; Smith KJ; DePasse J; Brown ST; Shim E; Nowalk MP; Wateska A; France GS; Zimmerman RK
    Vaccine; 2017 Oct; 35(42):5708-5713. PubMed ID: 28890196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cost-effectiveness of influenza vaccination in elderly Australians: an exploratory analysis of the vaccine efficacy required.
    Newall AT; Dehollain JP
    Vaccine; 2014 Mar; 32(12):1323-5. PubMed ID: 24486359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral agents for influenza: a comparison of cost-effectiveness data.
    Lynd LD; Goeree R; O'Brien BJ
    Pharmacoeconomics; 2005; 23(11):1083-106. PubMed ID: 16277546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.